NL300743I2 - - Google Patents

Download PDF

Info

Publication number
NL300743I2
NL300743I2 NL300743C NL300743C NL300743I2 NL 300743 I2 NL300743 I2 NL 300743I2 NL 300743 C NL300743 C NL 300743C NL 300743 C NL300743 C NL 300743C NL 300743 I2 NL300743 I2 NL 300743I2
Authority
NL
Netherlands
Application number
NL300743C
Other languages
Dutch (nl)
Other versions
NL300743I1 (en:Method
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300743(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of NL300743I1 publication Critical patent/NL300743I1/nl
Publication of NL300743I2 publication Critical patent/NL300743I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL300743C 2004-05-19 2015-06-16 NL300743I2 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV
PCT/EP2005/005377 WO2005111201A1 (en) 2004-05-19 2005-05-18 Vaccine comprising an attenuated pestivirus

Publications (2)

Publication Number Publication Date
NL300743I1 NL300743I1 (en:Method) 2016-01-26
NL300743I2 true NL300743I2 (en:Method) 2016-01-26

Family

ID=34967522

Family Applications (3)

Application Number Title Priority Date Filing Date
NL300743C NL300743I2 (en:Method) 2004-05-19 2015-06-16
NL300744C NL300744I1 (en:Method) 2004-05-19 2015-06-16
NL300745C NL300745I1 (en:Method) 2004-05-19 2015-06-16

Family Applications After (2)

Application Number Title Priority Date Filing Date
NL300744C NL300744I1 (en:Method) 2004-05-19 2015-06-16
NL300745C NL300745I1 (en:Method) 2004-05-19 2015-06-16

Country Status (26)

Country Link
EP (1) EP1751276B9 (en:Method)
JP (2) JP5006782B2 (en:Method)
KR (1) KR100908798B1 (en:Method)
CN (2) CN1989240B (en:Method)
AR (2) AR049176A1 (en:Method)
AT (1) ATE420949T1 (en:Method)
AU (1) AU2005243488B2 (en:Method)
BR (1) BRPI0510396B1 (en:Method)
CA (1) CA2561719C (en:Method)
CY (4) CY1109036T1 (en:Method)
DE (2) DE102004025452A1 (en:Method)
DK (1) DK1751276T5 (en:Method)
ES (1) ES2321210T3 (en:Method)
FR (3) FR15C0044I2 (en:Method)
HU (2) HUS1500031I1 (en:Method)
LU (3) LU92747I2 (en:Method)
ME (1) ME01119B (en:Method)
MX (1) MXPA06013298A (en:Method)
NL (3) NL300743I2 (en:Method)
NZ (1) NZ552088A (en:Method)
PL (1) PL1751276T3 (en:Method)
PT (1) PT1751276E (en:Method)
RS (1) RS50753B9 (en:Method)
SI (1) SI1751276T1 (en:Method)
UY (1) UY28905A1 (en:Method)
WO (1) WO2005111201A1 (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2066342B1 (en) * 2006-09-22 2014-07-23 Intervet International BV Bovine Viral Diarrhea Virus mutant for use in a vaccine
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CN102202685A (zh) 2008-10-31 2011-09-28 贝林格尔.英格海姆维特梅迪卡有限公司 包含来自牛枝原体的抗原的多种抗原在多价疫苗组合物中的用途
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
ES2606605T3 (es) 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
CN106456741B (zh) * 2014-05-23 2020-07-21 勃林格殷格翰动物保健有限公司 包含e2蛋白tav表位中的取代的重组经典猪瘟病毒(csfv)
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
EP1751276A1 (en) 2007-02-14
DK1751276T3 (da) 2009-05-18
DK1751276T5 (da) 2020-07-20
CY2015023I1 (el) 2020-05-29
CY2015021I1 (el) 2020-05-29
CA2561719A1 (en) 2005-11-24
RS50753B9 (sr) 2020-08-31
FR15C0042I2 (fr) 2018-11-16
FR15C0044I2 (fr) 2016-05-27
AR049176A1 (es) 2006-07-05
MXPA06013298A (es) 2007-05-07
JP2007537740A (ja) 2007-12-27
AU2005243488B2 (en) 2011-07-07
JP2012061001A (ja) 2012-03-29
PT1751276E (pt) 2009-02-24
CY2015021I2 (el) 2023-11-15
CY2015022I2 (el) 2024-02-16
CA2561719C (en) 2015-01-27
CN103352030A (zh) 2013-10-16
HUS1500033I1 (hu) 2015-07-28
AR104448A2 (es) 2017-07-19
HUS1500031I1 (hu) 2019-11-28
RS50753B (sr) 2010-08-31
KR20070012862A (ko) 2007-01-29
NL300743I1 (en:Method) 2016-01-26
LU92747I2 (fr) 2015-11-02
ME01119B (me) 2013-03-20
PL1751276T3 (pl) 2009-06-30
UY28905A1 (es) 2005-12-30
WO2005111201A1 (en) 2005-11-24
CY2015023I2 (el) 2024-02-16
DE602005012381D1 (de) 2009-03-05
AU2005243488A1 (en) 2005-11-24
NL300745I2 (en:Method) 2016-01-26
FR15C0044I1 (fr) 2015-07-24
NZ552088A (en) 2009-10-30
CN103352030B (zh) 2018-08-10
CY1109036T1 (el) 2014-07-02
NL300744I2 (en:Method) 2016-01-26
BRPI0510396B1 (pt) 2020-08-18
JP5562316B2 (ja) 2014-07-30
EP1751276B1 (en) 2009-01-14
NL300744I1 (en:Method) 2016-01-26
DE102004025452A1 (de) 2006-01-19
FR15C0042I1 (fr) 2015-07-24
SI1751276T1 (sl) 2009-06-30
CY2015022I1 (el) 2020-05-29
FR15C0043I2 (fr) 2016-05-27
JP5006782B2 (ja) 2012-08-22
ES2321210T9 (es) 2020-11-04
ES2321210T3 (es) 2009-06-03
FR15C0043I1 (fr) 2015-07-24
BRPI0510396A (pt) 2007-11-13
NL300745I1 (en:Method) 2016-01-26
LU92748I2 (fr) 2015-11-02
KR100908798B1 (ko) 2009-07-22
CN1989240B (zh) 2013-07-31
LU92749I2 (fr) 2015-11-02
CN1989240A (zh) 2007-06-27
ATE420949T1 (de) 2009-01-15
EP1751276B9 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
BE2023C542I2 (en:Method)
BE2020C513I2 (en:Method)
BE2019C548I2 (en:Method)
BE2017C023I2 (en:Method)
BE2016C020I2 (en:Method)
BE2015C063I2 (en:Method)
BE2015C066I2 (en:Method)
NL300743I2 (en:Method)
BE2015C011I2 (en:Method)
BE2015C036I2 (en:Method)
JP2004280112A5 (en:Method)
BR122018073034B8 (en:Method)
JP2006103395A5 (en:Method)
JP2006014640A5 (en:Method)
BRPI0508026A (en:Method)
JP2006157202A5 (en:Method)
JP2005228595A5 (en:Method)
JP2006097146A5 (en:Method)
JP2006108860A5 (en:Method)
BRPI0508033A (en:Method)
CN300950804S (zh) 钻夹头（10）
CN300741012S (zh) 瓶
CN300736035S (zh) 蒸汽发生器基座（1）
CN300736468S (zh) 净身盆
CN301315177S (zh) 衣架